The "Twelfth Five-Year Plan" of the pharmaceutical industry has been issued and put forward higher quantitative requirements

The target of the exhibition is obviously higher than that of the entire industry. The emphasis is on the development of biotechnology drugs, new varieties of chemical drugs, modern Chinese medicine, advanced medical devices, new types of pharmaceutical auxiliary materials and pharmaceutical equipment, and accelerating the development and application of new technologies in various fields and promoting Pharmaceutical industry transformation and upgrading and rapid development

On the 18th, the State Council officially issued the "Industrial Transformation and Upgrade Plan (2011-2015)" (Guo Fa [2011] No. 47). The plan was jointly prepared by the Ministry of Industry and Information Technology and the Development and Reform Commission, the Ministry of Science and Technology, the Ministry of Finance, the Ministry of Land and Resources, the Ministry of Environmental Protection, the Ministry of Commerce, the State-owned Assets Supervision and Administration Commission, the Department of National Defense Industry, and the Tobacco Bureau. For the first time, the entire industry was targeted for planning, and the State Council issued the medium and long-term plans for implementation.

Then, according to the “Twelfth Five-Year Plan for National Economic and Social Development”, “Opinions of the Central Committee and the State Council on Deepening the Reform of the Medical and Health System,” “Decision of the State Council on Accelerating the Cultivation and Development of Strategic Emerging Industries,” and the above The Twelfth Five-Year Development Plan for the Pharmaceutical Industry (2011-2015), prepared by the Industrial Transformation and Upgrading Program (2011-2015), is also officially issued by the Ministry of Industry and Information Technology, and is responsible for organizing the implementation of the plan.

Transformation and upgrading are the main theme

It can be said that the "Industrial Transformation and Upgrade Plan" is the action program guiding the transformation of China's industrial development mode in the next five years, and it is the specific implementation of the "Twelfth Five-Year Plan Outline of the People's Republic of China for National Economic and Social Development." It is also an industrial field. The important basis for the preparation of other plans, and "12th Five-year Development Plan of the pharmaceutical industry" is its specific implementation in the pharmaceutical sector.

According to the relevant person in charge of the Ministry of Industry and Information Technology, during the “12th Five-Year Plan” period, China is still in an important period of strategic opportunities that can accomplish much, but the internal and external environments of industrial development are undergoing profound changes, both the profound impact of the international financial crisis and the domestic economy. The urgent demands put forward by the change in the development approach have entered a critical period in which only the accelerated transformation and upgrading can achieve a sound and rapid development of the industry.

The "Industrial Transformation and Upgrade Plan" was launched under this background. The "Industrial Transformation and Upgrade Plan" pointed out that the transition is to accelerate the transition from a traditional industrialization path to a new type of industrialization path by changing the mode of industrial development; upgrading is to promote the industrial structure by comprehensively optimizing the technical structure, organizational structure, layout structure and industry structure. Overall optimization and improvement. Industrial transformation and upgrading involves the transformation of concepts, the transformation of models, and the innovation of paths. It is a strategic, overall, and systematic change process. Industrial transformation and upgrading is the key to accelerating the transformation of the economic development mode in China. It is the fundamental requirement for taking a new road to industrialization with Chinese characteristics, and it is also the only way to realize the transition from a large industrial country to an industrial power.

The "Industrial Transformation and Upgrading Plan" proposes that we should take scientific development as the theme and speed up the transformation of the development mode as the main line, insist on improving the quality and efficiency of development as the central task of transformation and upgrading, and strengthen independent innovation and technological progress as the key to transformation and upgrading. In the link, the development of resource-conserving and environment-friendly industries is regarded as an important focal point for transformation and upgrading, and the promotion of the integration of “two industries” is an important support for transformation and upgrading, and the improvement of the development level of industrial parks and industrial bases is an important focus for transformation and upgrading. We regard expanding openness and deepening reform as a powerful driving force for transformation and upgrading, continuously enhancing the industry’s core competitiveness and sustainable development capacity, and building industrial development on the basis of innovation-driven, intensive and efficient, environmentally friendly, benefiting people’s livelihood and endogenous growth. .

Higher goal of pharmaceutical industry planning

In the "Industrial Transformation and Upgrade Plan", the pharmaceutical industry belongs to the transformation and upgrading of the consumer goods industry. The "Industrial Transformation and Upgrade Plan" requires that brand building, quality of products, optimized distribution, and sincerity development should be the focus, increase effective supply, ensure quality and safety, guide consumption upgrades, promote orderly industrial transfer, and shape new competitive advantages in the consumer goods industry.

The "Industrial Transformation and Upgrade Plan" clarifies that the pharmaceutical industry should aim at improving the ability to prevent and treat major diseases and improve the health of residents, and accelerate the development and industrialization of key technologies for genetic engineering drugs, antibody drugs, new vaccines and major new products, and support the use of genes. Modern biotechnology such as engineering and enzyme engineering transform traditional pharmaceutical processes and processes. Strengthen R&D and industrialization of new chemical drugs, seize the opportunity of rapid growth in the world's generic drug market, and foster new advantages in the international market. Adhere to the combination of inheritance and innovation, develop modern Chinese medicines that are effective, have a clear material basis, have a clear mechanism of action, and have stable and controllable quality. Improve the development level of advanced medical equipment and high-end biomedical materials, and promote the development and industrialization of core technologies and key components. Promote the production of essential drugs to concentrate on advantageous enterprises and increase the level of production intensive and large-scale production. Promote the upgrading of drug quality standards and production quality management practices. The establishment of a military-civilian combination of emergency and special-purpose drug research and development and production systems should be established to improve the mechanism for the development and industrialization of ethnic drugs, and to meet the drug requirements for emergency treatment.

Not only that, the “Industrial Transformation and Upgrading Plan” has a higher quantitative requirement for the pharmaceutical industry: During the “12th Five-Year Plan” period, the average annual growth rate of the pharmaceutical industry's output value remains above 20%, which is higher than the average annual growth rate of all industrial added value 8 % of goal requirements.

The Twelfth Five-year Development Plan of the Pharmaceutical Industry has achieved stable and rapid growth from the scale of the industry, ensuring the supply of essential drugs, enhancing technological innovation capabilities, improving quality and safety, increasing industrial concentration, enhancing international competitiveness, and achieving results in energy conservation and emission reduction. In terms of various aspects, the objectives set forth in the above-mentioned "Industrial Transformation and Upgrade Plan" have been detailedly decomposed and concretely implemented.

For example, as far as technological innovation is concerned, the "12th Five-year Development Plan for the Pharmaceutical Industry" requires that: establish and improve a technology innovation system with enterprises as the main body; key R&D investment by key enterprises should reach more than 5% of sales revenue, and the ability to innovate should be significantly improved. In the “Twelfth Five-Year Plan” period, more than 30 original medicines have obtained new drug certificates, more than 30 generic new drug varieties have been developed, more than 200 major pharmaceutical varieties have been upgraded and upgraded, and more than 50 types of medical devices that possess core technologies have been developed. This requirement is also higher than the "industrial transformation and upgrading plan" for the industry's requirements of "industrial enterprises above designated size research and development (R & D) funds, the proportion of internal spending accounted for 1% of the main business income, key enterprises reached more than 3% ".

In the key areas of pharmaceutical development, the Twelfth Five-Year Development Plan for the Pharmaceutical Industry requires that: seizing the rapid growth of domestic and foreign pharmaceutical demand and major opportunities in the adjustment of global market structure, implementing the overall requirements for cultivating and developing strategic emerging industries, and vigorously developing biological resources New technology medicines, new varieties of chemical drugs, modern Chinese medicine, advanced medical devices, new types of pharmaceutical excipients, packaging materials and pharmaceutical equipment have accelerated the development and application of new technologies in various fields and promoted the transformation, upgrading and rapid development of the pharmaceutical industry.

It is reported that the "Industrial Transformation and Upgrading Plan" proposes eight safeguard measures to improve the industrial policy system and functions, strengthen industry standards and access conditions, and increase financial and taxation support, so as to ensure the smooth realization of major goals and tasks. The "12th Five-year Development Plan for the Pharmaceutical Industry" proposes that a cross-sectoral division of labor and collaboration and joint advancement of working mechanisms will be established, unified leadership and meticulous organization of planning and implementation will be strengthened, and planning and implementation details will be formulated to ensure that all tasks and measures are implemented. . Establish a plan to implement a dynamic assessment mechanism, do a good job in the monitoring of industry operations, timely analyze the development situation and release information, and guide the healthy development of the industry.